New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Alpha Tau Medical Ltd.
DRTS
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

154M

Biotechnology

Next Earning date - 21 Nov 2024

154M

Biotechnology

Next Earning date - 21 Nov 2024

2.20USD
Shape-0.03 ( -1.35%)
favorite-chart

Relative Strenght

16
favorite-chart

Volume Buzz

-29%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

44%

Quote Panel

Shape
Updated October 12, 2024
1W -3.08 % 1M -5.98 % 3M 3.77 % 1Y -42.86 %

Key Metrics

Shape
  • Market Cap

    153.83M


  • Shares Outstanding

    69.92M


  • Share in Float

    51.62M


  • Dividende

    0


  • Earning Date

    21 Nov 2024


  • Price Target

    2.2


  • Average Volume

    23692


  • Beta

    0.776


  • Range

    1.75-3.9


  • Industry

    Biotechnology


  • Website

    https://www.alphatau.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

2.08x

P/B Ratio

0.1

Debt/Equity

0.0%

Net Margin

$-0.4

EPS

How DRTS compares to sector?

P/E Ratio

Relative Strength

Shape

DRTS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1M

ShapeNaN%

2025-Revenue

$0.49

Shape-346%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.04
vs -0.07

Q4.22

arrow
arrow

N/A

-0.04
vs -0.08

Q1.23

arrow
arrow

N/A

-0.12
vs -0.54

Q2.23

arrow
arrow

N/A

-0.12
vs -0.03

Q3.23

arrow
arrow

N/A

-0.07
vs -0.04

Q4.23

arrow
arrow

N/A

-0.11
vs -0.04

Q1.24

arrow
arrow

N/A

-0.11
vs -0.12

Q2.24

arrow
arrow

N/A

-0.11
vs -0.12

Q3.24

arrow
arrow

N/A

-0.12
vs -0.07

Q4.24

arrow
arrow

N/A

-0.13
vs -0.11

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

62.5K  vs NA

Q4.24

arrow
arrow

NA

150K  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-2%

-0.02
vs -0.02

Q4.22

arrow
arrow

-3%

-0.03
vs -0.02

Q1.23

arrow
arrow

-8%

-0.08
vs -0.03

Q2.23

arrow
arrow

-9%

-0.09
vs -0.08

Q3.23

arrow
arrow

-5%

-0.05
vs -0.09

Q4.23

arrow
arrow

-9%

-0.09
vs -0.05

Q1.24

arrow
arrow

-10%

-0.10
vs -0.09

Q2.24

arrow
arrow

-10%

-0.10
vs -0.10

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

16

16
vs 13

23%

Q4.22

arrow
arrow

14

14
vs 16

-12%

Q1.23

arrow
arrow

16

16
vs 14

14%

Q2.23

arrow
arrow

20

20
vs 16

25%

Q3.23

arrow
arrow

23

23
vs 20

15%

Q4.23

arrow
arrow

26

26
vs 23

13%

Q1.24

arrow
arrow

27

27
vs 26

4%

Q2.24

arrow
arrow

24

24
vs 27

-11%

Earnings Growth

Latest News